ProfileGDS4132 / 226885_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 37% 30% 34% 37% 37% 40% 30% 47% 42% 40% 42% 35% 49% 54% 33% 40% 39% 41% 41% 46% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10195.606637
GSM201543Muscle PCOS pioglitazone 12164.4430
GSM201544Muscle PCOS pioglitazone 16187.92134
GSM201545Muscle PCOS pioglitazone 201102.66737
GSM201829Muscle PCOS pioglitazone 231100.8637
GSM201830Muscle PCOS pioglitazon 251105.98840
GSM201831Muscle PCOS pioglitazone 27171.207730
GSM201832Muscle PCOS pioglitazone 31123.90147
GSM201833Muscle PCOS pioglitazone 41102.66842
GSM201834Muscle PCOS pioglitazone 81101.88740
GSM201835Muscle PCOS after pioglitazone 10295.170142
GSM201836Muscle PCOS after pioglitazone 12278.657735
GSM201837Muscle PCOS after pioglitazone 162114.7849
GSM201838Muscle PCOS after pioglitazone 202136.6654
GSM201839Muscle PCOS after pioglitazone 23276.721733
GSM201840Muscle PCOS after pioglitazone 25298.343540
GSM201841Muscle PCOS after pioglitazone 27285.005739
GSM201842Muscle PCOS after pioglitazone 3287.736141
GSM201843Muscle PCOS after pioglitazone 42103.23141
GSM201844Muscle PCOS after pioglitazone 82116.16846